Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans

NCT01600703 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: Sitagliptin
DRUG: Placebo

Sponsor

University Health Network, Toronto

Collaborators

[object Object]